Literature DB >> 19074584

Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes.

Qi Ding1, Tomas Mracek, Pedro Gonzalez-Muniesa, Katarina Kos, John Wilding, Paul Trayhurn, Chen Bing.   

Abstract

Macrophage inhibitory cytokine-1 (MIC-1), a divergent member of the TGF-beta superfamily, is involved in the control of multiple cellular processes and mediates cachexia through the inhibition of appetite. Adipose tissue as an endocrine organ secretes proteins (adipokines) that regulate energy homeostasis and other cellular functions. This study investigated whether MIC-1 is expressed in adipose tissue and whether MIC-1 is a secretory product of adipocytes. Mouse and human adipose tissues were collected from different depots. 3T3-L1 preadipocytes and human preadipocytes were induced to differentiate into adipocytes in cell culture. MIC-1 mRNA was detected in the major mouse adipose depots (epididymal, perirenal, sc). In these depots, MIC-1 gene expression was evident in both isolated mature adipocytes and stromal-vascular cells. In 3T3-L1 adipocytes, MIC-1 mRNA was detected before and after differentiation. MIC-1 mRNA and protein secretion were evident in human preadipocytes as well as differentiated adipocytes. MIC-1 production by human adipocytes was stimulated by H(2)O(2) and 15d-prostaglandin J(2). In addition, recombinant MIC-1 increased adiponectin secretion by differentiated human adipocytes. MIC-1 mRNA and protein were also observed in human sc and visceral fat. MIC-1 mRNA levels were positively correlated with adiponectin mRNA. Moreover, MIC-1 mRNA was negatively associated with body mass index and body fat mass in human subjects. We conclude that MIC-1 is expressed in adipose tissue and secreted from adipocytes and is therefore a new adipokine. MIC-1 may have a paracrine role in the modulation of adipose tissue function and body fat mass.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074584     DOI: 10.1210/en.2008-0952

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  65 in total

1.  Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.

Authors:  Anand Rohatgi; Parag Patel; Sandeep R Das; Colby R Ayers; Amit Khera; Abelardo Martinez-Rumayor; Jarett D Berry; Darren K McGuire; James A de Lemos
Journal:  Clin Chem       Date:  2011-11-07       Impact factor: 8.327

2.  Elevated GDF-15 contributes to pulmonary inflammation upon cigarette smoke exposure.

Authors:  F M Verhamme; L J M Seys; E G De Smet; S Provoost; W Janssens; D Elewaut; G F Joos; G G Brusselle; K R Bracke
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

Review 3.  The development of gene therapy for diseases of the lung.

Authors:  D R Gill; L A Davies; I A Pringle; S C Hyde
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

Review 4.  Cardiac biomarkers: new tools for heart failure management.

Authors:  Navaid Iqbal; Bailey Wentworth; Rajiv Choudhary; Alejandro De La Parra Landa; Benjamin Kipper; Arrash Fard; Alan S Maisel
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

5.  Mechanisms of Adipocytokine-Mediated Trastuzumab Resistance in HER2-Positive Breast Cancer Cell Lines.

Authors:  Samantha E Griner; Katherine J Wang; Jayashree P Joshi; Rita Nahta
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-03-01

6.  GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.

Authors:  Shannon E Mullican; Xiefan Lin-Schmidt; Chen-Ni Chin; Jose A Chavez; Jennifer L Furman; Anthony A Armstrong; Stephen C Beck; Victoria J South; Thai Q Dinh; Tanesha D Cash-Mason; Cassandre R Cavanaugh; Serena Nelson; Chichi Huang; Michael J Hunter; Shamina M Rangwala
Journal:  Nat Med       Date:  2017-08-28       Impact factor: 53.440

7.  Proteomic identification of potential markers of myosteatosis in human urine.

Authors:  Holger Husi; Alisdair MacDonald; Richard J E Skipworth; Janice Miller; Andrew Cronshaw; Kenneth C H Fearon; James A Ross
Journal:  Biomed Rep       Date:  2018-04-25

8.  Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Authors:  Thomas J Wang; Kai C Wollert; Martin G Larson; Erin Coglianese; Elizabeth L McCabe; Susan Cheng; Jennifer E Ho; Michael G Fradley; Anahita Ghorbani; Vanessa Xanthakis; Tibor Kempf; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan; James L Januzzi
Journal:  Circulation       Date:  2012-08-20       Impact factor: 29.690

9.  Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation.

Authors:  Ivana Dostálová; Petra Kaválková; Hana Papežová; Daniela Domluvilová; Vít Zikán; Martin Haluzík
Journal:  Nutr Metab (Lond)       Date:  2010-04-23       Impact factor: 4.169

10.  Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.

Authors:  R J E Skipworth; D A C Deans; B H L Tan; K Sangster; S Paterson-Brown; D A Brown; M Hunter; S N Breit; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.